Upgrade to SI Premium - Free Trial

Vanda Pharmaceuticals (VNDA) PT Raised to $13 at Cantor Fitzgerald

August 1, 2024 6:35 AM
Cantor Fitzgerald analyst Charles Duncan raised the price target on Vanda Pharmaceuticals (NASDAQ: VNDA) to $13.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles